InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Explore the complete record of transactions filed by Maharaj Gary R, Chairman & CEO. Officer active across 2 companies, notably SURMODICS INC. In total, 11 reports have been published. Total volume traded: €1.3m. The latest transaction was disclosed on 1 April 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations11 total
€158,4123,900 shares@ €40.618416.8% of flow
Common Stock
SEC:0001209191-22-023199:0·
€102,6542,639 shares@ €38.898713.1% of flow
Common Stock
SEC:0001209191-21-067517·
€102,6542,639 shares@ €38.898710.9% of flow
Common Stock
SEC:0001209191-21-067517:0·
€92,7702,172 shares@ €42.711911.8% of flow
Common Stock
SEC:0001209191-21-066992·
€92,7702,172 shares@ €42.71199.8% of flow
Common Stock
SEC:0001209191-21-066992:0·
€274,1755,800 shares@ €47.271534.9% of flow
Common Stock
SEC:0001209191-21-062477·
€274,1755,800 shares@ €47.271529.1% of flow
Common Stock
SEC:0001209191-21-062477:0·
€265,9565,500 shares@ €48.355733.9% of flow
Common Stock
SEC:0001209191-21-059344·
€265,9565,500 shares@ €48.355728.2% of flow
Common Stock
SEC:0001209191-21-059344:0·
€49,3931,030 shares@ €47.95476.3% of flow
Common Stock
SEC:0001209191-21-056609·
€49,3931,030 shares@ €47.95475.2% of flow
Common Stock
SEC:0001209191-21-056609:0·
11 of 11 declarations
About Maharaj Gary R
Gary R. Maharaj is the Chief Executive Officer of Surmodics Inc. He is responsible for the strategic and operational direction of the company, which focuses on health solutions. Maharaj is committed to promoting innovation and improving patient outcomes.
